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Abstract 
Purpose: Toll-like receptor 4 (TLR4) is known to be involved in innate immunity and inflammatory responses that 
play important roles in the pathogenesis of coronary artery disease (CAD). But the relationship between TLR4 gene 
and CAD has yet to be investigated. The present study aimed to evaluate the association of TLR4 gene polymorphisms 
with CAD susceptibility in a Chinese Han population.
Methods: A total of 1094 subjects (577 unrelated patients with CAD and 517 controls) were recruited between 2008 
and 2012. Three tag SNPs (rs1927907, rs1927911 and rs11536889) present in the TLR4 gene were genotyped using 
Sequenom Mass-ARRAY system.
Results: The genotypic distributions of the three SNPs were not deviate from Hardy–Weinberg equilibrium. There 
was no significant difference in distributions of allelic frequencies of each SNPs between healthy controls and CAD 
patients (P > 0.05). Genotype frequencies of TLR4 gene did not show any statistically significant difference between 
the two groups in co-dominant, dominant or recessive genetic models (P > 0.05). The frequency of haplotypes in the 
case group was similar to that in the control group (P > 0.05).
Conclusion: TLR4 gene do not relate to genetic susceptibility of CAD in the Chinese Han population.
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Background
Coronary artery disease (CAD) is the leading cause of 
morbidity and mortality worldwide (Roger et  al. 2012). 
As a complex disease, the main pathological features of 
CAD are atherosclerotic changes, which include vascular 
endothelial damage, adhesion and migration of mono-
cytes, lipid accumulation in macrophages, and the forma-
tion of foam cells (Fredman and Spite 2013). A chronic 
inflammatory process is contributed to atherosclerosis. 
Moreover, activation of innate immunity system and 
chronic low-grade inflammation play important roles in 
all phases of atherosclerosis, including initiation, pro-
gression, and thrombotic complications (Libby 2012; 
Libby et al. 2010).
Toll-like receptors (TLRs) are a group of pathogen-
associated molecular pattern receptors involved in innate 
immunity and pathogen recognition. To date, at least 13 
TLRs have been discovered in mammals (O’Neill 2008). 
Toll-like receptor 4 (TLR4) belongs to the TLRs family and 
is expressed in cardiomyocytes, monocytoes, endothe-
lial cells (Zarember and Godowski 2002) and cells of the 
central nervous system (Kielian 2006). TLR4 can ligate 
with not only the exogenous ligand lipopolysaccharide, 
in particular from gram-negative bacteria, but also sev-
eral endogenous ligands, such as endogenous molecules 
released by injured tissues and necrotic cells. These mol-
ecules, called damage-associated molecular pattern mol-
ecules, induce the activation of a strong proinflammatory 
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response through interaction with TLR4 (Molteni et  al. 
2016). Recognition of these ligands by TLR4 contributes 
to activation of signaling events that can elicit the pro-
inflammatory cytokine release, lipid uptake, foam cell for-
mation and even activate adaptive immune system (Cole 
et al. 2010). Stimulated TLR4 signaling results in the up-
regulation of TNF-α production in macrophages, what 
is particularly important in terms of tissue inflammation 
(Nagai et al. 2013). Previous studies have showed that the 
expression of TLR4 was markedly enhanced in human 
atherosclerotic plaques and this augmentation occurred 
preferentially on macrophages and endothelial cells 
(Edfeldt et  al. 2002; Vink et  al. 2002; Otsui et  al. 2007). 
An animal study also validated that TLR4-deficient mice 
sustained significantly smaller infarctions and lower level 
of inflammatory responses compared with wild-type con-
trol mice (Takeishi and Kubota 2009). These revealed a 
fact that TLR4 might be an important susceptibility gene 
to CAD via its role in activation of innate immunity and 
inflammatory responses.
TLR4 gene is located on chromosome 9 (9q32-q33) and 
consists of four exons and three introns. So far, 29 single 
nucleotide polymorphisms (SNPs) have been identified in 
the TLR4 gene. With the use of SNPs as molecular mark-
ers, many genetic association studies were performed to 
investigate the associations of TLR4 gene polymorphisms 
with the risk of CAD (Kolek et  al. 2004; Balistreri et  al. 
2004; Incalcaterra et al. 2010; Zee et al. 2005; Koch et al. 
2006; Nebel et  al. 2007; Džumhur et  al. 2012). However, 
results of these studies are not always consistent. Some of 
them showed that TLR4 gene polymorphisms were associ-
ated with a lower risk of CAD (Kolek et al. 2004; Balistreri 
et al. 2004; Incalcaterra et al. 2010), while the others found 
no relationship between them (Zee et al. 2005; Koch et al. 
2006; Nebel et al. 2007; Džumhur et al. 2012). All of above 
studies were performed in Caucasian populations and paid 
attention to two missense polymorphisms in the TLR4 
(Asp299Gly and Thr399Ile). Because both Asp299Gly and 
Thr399Ile are very rare in Chinese population, there are 
few relevant studies about the association of TLR4 gene 
polymorphisms with CAD (Hang et al. 2004).
Considering TLR4 plays an important role in the 
pathogenesis of CAD, we hypothesized those common 
polymorphisms in the TLR4 gene might predispose 
human to CAD. Therefore, the aim of this study was to 
explore the association between tag SNPs, which capture 
all the essential information about the TLR4 gene locus, 
and CAD in a Chinese Han population.
Results
Characteristics of study subjects
The demographic and clinical characteristics of the 577 
CAD patients and 517 control subjects are presented 
in Table  1. Compared with the control group, the CAD 
group had more smokers and more individuals with 
hypertension and with diabetes. Significant higher in age, 
WHR and TC was pronounced in the CAD group. There 
was no significant difference in gender, BMI, TG and 
prevalence of drinking status between the control and 
case groups.
TLR4 polymorphisms and CAD risk
Three SNPs (rs1927907, rs1927911 and rs11536889) in 
TLR4 were genotyped. All genotype distributions in both 
control and case groups were in Hardy–Weinberg equi-
librium (P > 0.05, Table 2).
The allele frequencies of the 3 SNPs are listed in Table 3. 
There were no significant differences between healthy 
controls and CAD patients (P  >  0.05). After adjustment 
for traditional risk factors including age, WHR, TC, his-
tory of hypertension and diabetes, and smoking status, 
no statistically association of the three SNPs with CAD 
was found between the case and control group (P > 0.05).
We further compared the genotypic frequencies of 
each SNP between the two groups by using co-dominant, 
dominant and recessive genetic models. After adjustment 
for above confounding factors, the result showed that 
TLR4 gene polymorphisms were not associated with the 
risk of CAD (P > 0.05, Table 3).
Haplotype analysis
Three tag SNPs selected in our study were located in 
one haplotype block, and the magnitude of LD between 
each SNP was extremely high, with pair-wise D′ > 0.94. 




Characteristic Control (n = 517) Case (n = 577) P
Acute coronary 
syndrome, n (%)
– 266 (46.1) –
Gender, n (%)
 Female 252 (48.7) 270 (46.8) 0.519
 Male 265 (51.3) 307 (53.2)
Age (years)a 63.75 ± 11.56 61.70 ± 12.75 0.080
BMI (kg/m2)b 24.02 ± 3.28 24.11 ± 2.73 0.691
WHRa 0.88 ± 0.09 0.93 ± 0.07 <0.001
Hypertension (%) 109 (31.6) 245 (56.1) <0.001
Diabetes (%) 43 (12.5) 126 (23.8) <0.001
Smoking (%) 84 (23.6) 199 (37.1) <0.001
Drinking (%) 80 (22.5) 112 (21.2) 0.625
TC (mmol/L)b 4.64 ± 1.22 5.04 ± 1.06 <0.001
TG (mmol/L)a 1.74 ± 1.06 1.74 ± 1.14 0.611
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The haplotype analysis was performed to derive haplo-
types specifically correlated with CAD susceptibility. As 
show in Table 4, although four common TLR4 haplotypes 
(frequency >10  %) were found, there was no significant 
differences in the haplotype distributions between the 
control and case groups (P > 0.05).
Quantitative trait analysis
The levels of TC and TG in the patient group were con-
sidered as quantitative trait to analyze their relationship 
with the 3 SNPs, respectively. However, neither of the 
two plasma lipid parameters showed association for the 
three SNPs (Table 5).
Genotype association for hypertension and diabetes
Tables 6 and 7 analyzed the genotype association of the 
3 SNPs with hypertension and diabetes in CAD patients. 
Neither of them showed association for the three SNPs.
Discussion
In the present study, three tag SNPs (rs1927907, 
rs1927911 and rs11536889) in the TLR4 gene were geno-
typed to investigate the association between TLR4 gene 
polymorphisms and the risk of CAD. The minor allele 
frequencies of these SNPs in the control group were 
26.7, 58.6 and 20.5  %, respectively, which were similar 
to that in the HapMap-CHB reference population. After 
Table 2 Distribution of allele frequencies of SNPs in control and case groups
* Adjustment for WHR, TC, history of hypertension and diabetes and smoking status
SNPs Group HWE Allele numbers (%) χ2 P OR (95 % CI)*
Major allele Minor allele
rs11536889 Control 0.454 820 (79.5) 212 (20.5) 0.506 0.477 1.104 (0.806, 1.512)
Case 0.619 890 (78.2) 248 (21.8)
rs1927907 Control 0.926 752 (73.3) 274 (26.7) 0.583 0.445 1.095 (0.813, 1.474)
Case 0.542 849 (74.7) 287 (25.3)
rs1927911 Control 0.713 425 (41.4) 601 (58.6) 0.161 0.689 0.910 (0.699, 1.184)
Case 0.272 465 (40.6) 681 (59.4)
Table 3 Association of SNPs with CAD in different genetic models
* Adjustment for WHR, TC, history of hypertension and diabetes and smoking status
SNPs Model Genotype Control (%) Case (%) χ2 P OR (95 % CI)*
rs11536889 Co-dominant G/G 323 (62.6) 346 (60.8) 0.570 0.752 1.00
G/C 174 (33.7) 198 (34.8) 1.055 (0.714, 1.558)
C/C 19 (3.7) 25 (4.4) 1.293 (0.503, 3.326)
Dominant G/G 323 (62.6) 346 (60.8) 0.366 0.545 1.00
G/C+C/C 193 (37.4) 223 (39.2) 1.100 (0.755, 1.603)
Recessive G/G+G/C 497 (96.3) 544 (95.6) 0.352 0.553 1.00
C/C 19 (3.7) 25 (4.4) 1.270 (0.498, 3.235)
rs1927907 Co-dominant G/G 276 (53.8) 320 (56.3) 0.702 0.704 1.00
A/G 200 (39.0) 209 (36.8) 1.126 (0.764, 1.659)
A/A 37 (7.2) 39 (6.9) 1.139 (0.534, 2.429)
Dominant G/G 276 (53.8) 320 (56.3) 0.701 0.402 1.00
A/G+A/A 237 (46.2) 248 (43.7) 1.134 (0.783, 1.643)
Recessive G/G+A/G 476 (92.8) 529 (93.1) 0.049 0.824 1.00
A/A 37 (7.2) 39 (6.9) 1.085 (0.517, 2.275)
rs1927911 Co-dominant T/T 86 (16.8) 88 (15.4) 0.409 0.815 1.00
C/T 253 (49.5) 289 (50.4) 0.844 (0.494, 1.442)
C/C 174 (33.7) 196 (34.2) 0.797 (0.455, 1.398)
Dominant T/T 86 (16.8) 88 (15.4) 0.398 0.528 1.00
C/T+C/C 427 (83.2) 485 (84.6) 0.824 (0.496, 1.370)
Recessive T/T+C/T 340 (66.3) 377 (65.8) 0.028 0.867 1.00
C/C 173 (33.7) 196 (34.2) 0.926 (0.630, 1.361)
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systemic analysis, we found no evidence to support a sig-
nificant association between TLR4 gene polymorphisms 
and CAD susceptibility.
TLR4 is a type 1 transmembrane protein that medi-
ates immune responses to both endogenous and exog-
enous ligands (O’Neill 2008). On binding of the specific 
ligands, TLR4 triggers signal transduction that induces 
the production and secretion of pro-inflammatory 
cytokines and chemokines through myeloid differen-
tiation primary-response protein 88 (MyD88) or TIR 
domain-containing adaptor inducing IFN-β (TRIF) 
dependent signaling pathways, as appropriate (Senevi-
ratne et al. 2012). Therefore, TLR4 plays a crucial role in 
the pathogenesis of CAD, while genetic variations within 
the gene have an important influence on the pathogen-
esis. A polymorphism Asp299Gly, resulting in amino 
acid exchange in the extracellular domain of the recep-
tor, is associated with a blunted inflammatory response 
(Arbour et  al. 2000). This might lead to altered risk of 
CAD. Previous studies have been performed to inves-
tigate the association of the polymorphism Asp299Gly 
with CAD susceptibility in Caucasian populations, albeit 
with conflicting results. Some of these studies showed 
that the minor G allele was associated with a reduced risk 
of CAD and acute coronary events (Kolek et al. 2004; Bal-
istreri et al. 2004; Incalcaterra et al. 2010; Ameziane et al. 
2003; Edfeldt et al. 2004; Kutikhin et al. 2016; Boekholdt 
et  al. 2003; Holloway and Yang 2005), while the others 
found no relationship between them (Zee et  al. 2005; 
Koch et al. 2006; Nebel et al. 2007; Džumhur et al. 2012; 
Golovkin et  al. 2014; Morange et  al. 2004; Hernesniemi 
et al. 2006; Lima-Neto et al. 2013). A meta-analysis indi-
cated that Asp299Gly polymorphism was not associated 
with MI risk (Yin et al. 2014). However, the prevalence of 
Asp299Gly polymorphism is very low in Chinese popula-
tion. Liu et al. (2012) and Lin et al. (2005) even failed to 
detect the presence of any variant for the SNP. So we did 
not investigate the role of the less common non-synony-
mous SNP in our study. Beside Asp299Gly polymorphism 
within TLR4 gene, a study investigated the association 
between four new substitutions found by re-sequencing 
in the 5  V-proximal promoter region of the TLR4 gene 
and acute myocardial infarction, but they did not find 
the association (De Staercke et  al. 2007). We selected 
three tag SNPs for genetic analysis, including rs1927907, 
rs1927911 and rs11536889. Although any of them are not 
in exon, they are useful to find the disease-related vari-
ants because they capture abundant genetic information 
in the TLR4 gene based on the CHB dbSNP database.
Two SNPs, rs1927907 and rs1927911, are located in 
intron. Introns are identified to have evolved to func-
tion as endogenous network control molecules, enabling 
direct gene–gene communication and multitasking of 
eukaryotic genomes, and are important in genetic expres-
sion and regulation (Mattick and Gagen 2001). A report 
regarding the relationship between the TLR4 gene poly-
morphisms and late-onset Alzheimer’s disease (LOAD) 
showed that participants with AA genotype of rs1927907 
had a significantly increased risk of LOAD (Chen et  al. 
2012). The minor allele C of rs1927911 was previously 
demonstrated to be associated with normal tension 
glaucoma (Takano et al. 2012; Shibuya et al. 2008), can-
cer (Zhang et al. 2013; Song et al. 2009) and pulmonary 
tuberculosis (Zaki et al. 2012). In our study, however, no 
statistically association was found between genetic varia-
tions in the rs1927907 and rs1927911 locus and the risk 
of CAD. The result is inconsistent with a relevant study 
performed in a Washington population, which revealed 
that minor allele C of rs1927911 was associated with a 
Table 4 Haplotype frequencies of SNPs in control and case 
groups
Global: χ2 = 3.557, df = 6, P = 0.736
a Haplotypes with frequency >10 % were listed
Haplotypea Control (%) Case (%) χ2 P
rs1927911-rs1927907-
rs11536889
CGC 206 (20.2) 236 (21.2) 0.420 0.517
CGG 392 (38.5) 427 (38.3) 0.014 0.907
TAG 271 (26.6) 279 (25.0) 0.575 0.449
TGG 147 (14.4) 166 (14.9) 0.088 0.767
Table 5 Quantitative trait analysis for allelic association of the 3 SNPs with plasma lipid levels in patients with CAD
Lipid SNPs Major allele (%) Minor allele (%) Variance χ2 P
TC rs11536889 890 (78.2) 248 (21.8) 2.002 2.448 0.118
rs1927907 849 (74.7) 287 (25.3) 2.076 1.306 0.253
rs1927911 464 (40.5) 682 (59.5) 2.050 0.005 0.944
TG rs11536889 890 (78.2) 248 (21.8) 1.321 3.072 0.788
rs1927907 849 (74.7) 287 (25.3) 1.331 0.309 0.578
rs1927911 464 (40.5) 682 (59.5) 1.311 0.688 0.407
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12  % lower MI risk (Enquobahrie et  al. 2008). The rea-
son which can account for this contradictory result is the 
ethnic difference. The previous study was performed in a 
Caucasian population, while our study in a Chinese Han 
population.
The SNP rs1156889 is located in the 3′-UTR of the 
TLR4 gene, where the sequence may influence mRNA 
stability, translation and localization and thereby regu-
late expression of the gene and interfere with the host 
immune system. In previous studies, the rs11536889 C 
was showed to be significantly associated with a high risk 
of emphysema (Ito et al. 2012) and prostate cancer (Kim 
et al. 2012). However, our study did not find any signifi-
cant association between this SNP and CAD, relating to 
allele, genotype and haplotype analysis.
As a complex disease, there are overly confound-
ing variables and genetic mechanisms that can lead 
to CAD. Analyzing the genetic variants can probably 
represent the first step to understand the pathophysi-
ology of CAD, but can not explain the whole effect 
of TLR4 on CAD. Conditions of patients with CAD, 
such as hypertension, diabetes and plasma lipid lev-
els, may influence the effect. Schneider S et  al. had 
demonstrated an association between the TLR4 SNP 
rs4986790 genotype and age-dependant blood pres-
sure increase in patients with coronary artery disease 
(Schneider et  al. 2015). In order to take into consid-
eration these factors affecting TLR4 genetic analysis in 
CAD, We investigate the combined effect of TLR4 and 
some common risk factors on the development of the 
disease. The results showed that there was no geno-
type association for plasma lipid levels, hypertension 
and diabetes. This suggested the plasma lipid levels, 
hypertension and diabetes did not influence the effect 
of TLR4 on CAD.
Conclusion
The present study suggests that TLR4 polymorphisms are 
not associated with CAD in the Chinese Han population. 
This study, to our knowledge, is the first attempt to assess 
the association of the three tag SNPs in TLR4 gene with 
CAD in Chinese Han population and must contribute 
valuable information to the future relevant studies.
Methods
Study population
A total of 577 unrelated patients with CAD were 
recruited from the First Hospital of Jilin Univer-
sity between 2008 and 2012, including 266 patients 
with acute coronary syndrome. CAD was defined as 
the result of standardized coronary angiography and 
the diagnostic criteria of it was a ≥50  % stenosis in 
one or more main coronary arteries. All the angiog-
raphies were interpreted with the consensus from at 
least two independent cardiologists who were blinded 
to the results of the genetic analysis. Individuals were 
excluded if they suffered from congenital heart dis-
ease, cardiomyopathy, hepatic or renal disease and 
cancer. Control subjects (n  =  517), residing in the 
same geographical area as the cases, were randomly 
selected from the persons who were through the rou-
tine checkup as part of annual body examination. They 
were classified as healthy controls based on the results 
of physical examination coupled with the absence of 
any reasons to suspect CAD.
Clinical data, including age, gender, body mass index 
(BMI), waist-to-hip ratio (WHR), hypertension, diabetes 
mellitus, smoking and drinking status, total cholesterol 
(TC) and triglyceride (TG), were obtained from all par-
ticipants. Blood samples were collected in tubes contain-
ing EDTA and stored at −80 °C until extraction.
Table 6 Genotype association of the 3 SNPs with hypertension in patients with CAD
SNPs Major–major Major–minor Minor–minor χ2 P
No (%) Yes (%) No (%) Yes (%) No (%) Yes (%)
rs11536889 45.9 54.1 33.8 68.2 44.0 56.0 2.072 0.355
rs1927907 40.7 59.3 48.1 51.9 42.9 57.1 2.202 0.333
rs1927911 42.0 48.0 43.9 46.1 46.8 43.2 0.417 0.812
Table 7 Genotype association of the 3 SNPs with diabetes mellitus in patients with CAD
SNPs Major–major Major–minor Minor–minor χ2 P
No (%) Yes (%) No (%) Yes (%) No (%) Yes (%)
rs11536889 78.4 21.6 71.0 29.0 75.0 25.0 3.448 0.178
rs1927907 74.8 25.2 76.7 23.3 85.7 14.3 2.084 0.353
rs1927911 76.8 23.2 74.0 26.0 81.2 18.8 1.871 0.392
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Every subject gave a written informed consent and was 
well told of the study protocol. The study was approved 
by the ethics committee of school of public health, Jilin 
University, Changchun, China.
SNPs selection and genotyping
The data of reported TLR4 SNPs for Chinese Han pop-
ulation in Beijing was obtained from the International 
HapMap Project (www.hapmap.org). Based on the cri-
teria of minor allele frequencies (MAFs) ≥0.10 and link-
age disequilibrium of r2 > 0.8, three SNPs were selected 
for genetic analysis. There are rs1927907 and rs1927911, 
located in the intron of TLR4 gene, while rs11536889 in 
the 3′ untranslated region.
Genomic DNA was extracted from peripheral blood 
lymphocytes using a DNA extraction kit (TianGen, Bei-
jing, China). Genotypes of SNPs were detected using 
Sequenom Mass-ARRAY system with genotyping suc-
cess rate greater than 96 % for each SNP. The amplifica-
tion primers and extension primers are listed in Table 8. 
For quality control, 30 random samples were genotyped 
repetitively together with others, and the concordance 
rate was 100 %.
Continuous variables were expressed as median ± QR 
or mean ± SD and were compared by student’s t test or 
the Mann–Whitney U test, as appropriate. Categori-
cal variables were expressed as counts (percentage) and 
were compared with Pearson χ2 test. The Hardy–Wein-
berg equilibrium for the genotypic distributions of SNPs 
was tested using the χ2 goodness-of fit test. The uncon-
ditional logistic regression models were performed 
to calculate the odds ratios (OR) and 95  % confidence 
intervals (CI). Three inheritance models (co-dominant, 
dominant and recessive) were defined and were applied 
to genotypic analysis. Genotype association for diabetes 
mellitus and hypertension was performed with χ2 test. 
The values of linkage disequilibrium (LD) between all 
pairs of biallelic loci were calculated using Haploview 
software (Version 4.2). Haplotypic analysis and quanti-
tative trait tests were performed with the UNPHASED 
program (Version 3.0.12). A two-tailed P value <0.05 
was considered to be statistically significant. Statistical 
analysis was carried out using SPSS 13.0 for Windows 
software.
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